Food and Drug Regulations, C.R.C., c. 870
Section C.08.003.01
Cite as Food and Drug Regulations, C.R.C., c. 870, s. C.08.003.01 · current to June 17, 2026 · regulation last amended June 17, 2026
Statute Watch
Get an alert when a bill in Parliament would change this section, and every time it moves.
The text
(1) The following definitions apply in this section.
submission means
(a) a new drug submission that is filed under section C.08.002;
(b) an extraordinary use new drug submission that is filed under section C.08.002.01;
(c) an abbreviated new drug submission that is filed under section C.08.002.1; or
(d) an abbreviated extraordinary use new drug submission that is filed under section C.08.002.1. (présentation)
supplement means a supplement to a submission that is filed under section C.08.003. (supplément)
(2) Despite sections C.08.002, C.08.002.01, C.08.002.1 and C.08.003 and subject to subsection (3), the manufacturer of a new drug is not permitted to file a submission or supplement for the new drug on the basis of a direct or indirect comparison to any new drug in respect of which an authorization was issued under the ISAD Interim Order.
(3) Subsection (2) does not prevent the manufacturer of a new drug from filing a submission or supplement for the new drug on the basis of a direct or indirect comparison to another new drug in respect of which an authorization was issued under the ISAD Interim Order if
(a) a notice of compliance is issued under section C.08.004 or C.08.004.01 in respect of a submission or supplement for that other new drug; and
(b) the comparison is in respect of the matters that were approved by the notice of compliance.
Read the Food and Drug Regulations on the Justice Laws Website ↗
Made under Food and Drugs Act, R.S.C. 1985, c. F-27.
Bills in Parliament that would change this section 0
No bill we hold would amend or repeal this section.